Introducing Olanzapine + Fluoxetine HCl Capsules by PharmAlliance International Labs Private Limited

At PharmAlliance International Labs Private Limited, we are deeply committed to enhancing mental health outcomes through innovative medication solutions. Our Olanzapine + Fluoxetine HCl Capsules represent a groundbreaking approach to addressing complex psychiatric conditions, harnessing the therapeutic benefits of olanzapine and fluoxetine in a single formulation. With a paramount focus on patient well-being and safety, we endeavor to provide effective treatment options for individuals navigating the challenges of mental health disorders.

Drug Classification:

Olanzapine + Fluoxetine HCl Capsules belong to the esteemed class of drugs known as antipsychotics and antidepressants. This unique combination medication offers synergistic effects, targeting both psychotic symptoms and depressive episodes, thereby proving particularly efficacious in treating conditions such as bipolar disorder and treatment-resistant depression.

Formulations:

Our Olanzapine + Fluoxetine HCl Capsules are available in two distinct formulations:

Olanzapine 3mg + Fluoxetine 25mg

Olanzapine 6mg + Fluoxetine 25mg

Presented in the form of oral capsules for easy administration, each pack contains 14 capsules, ensuring convenience and compliance for patients.

Indications:

These capsules are indicated for the treatment of various conditions, including:

Bipolar Disorder: Effective in managing acute depressive episodes associated with bipolar I disorder and preventing depressive relapse.

Treatment-Resistant Depression: Provides relief from symptoms that have not responded adequately to other antidepressant medications.

Psychotic Disorders: Addresses both depressive and psychotic symptoms, making it suitable for individuals with co-occurring features.

Usage:

Patients are advised to take Olanzapine + Fluoxetine HCl Capsules orally, swallowing them whole with water, with or without food. It is imperative to adhere to the prescribed dosage and dosing schedule as directed by a healthcare professional to optimize treatment outcomes.

Dosage:

The recommended starting dose varies depending on the individual’s condition and treatment history. Dosage adjustments may be made based on clinical response and tolerability under the guidance of a healthcare professional.

Pharmacokinetics:

Both olanzapine and fluoxetine undergo extensive hepatic metabolism via the cytochrome P450 enzyme system. The pharmacokinetics of this combination medication are influenced by factors such as hepatic function, drug interactions, and individual patient characteristics.

Pharmacodynamics:

Olanzapine exerts its antipsychotic effects through its antagonism of dopamine and serotonin receptors, alleviating psychotic symptoms. Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), enhances mood by increasing serotonin levels in the brain.

Side Effects:

Common side effects may include drowsiness, dizziness, weight gain, dry mouth, and constipation. Less common but potentially serious side effects should be promptly reported to a healthcare provider for further evaluation.

Trust in the efficacy and safety of Olanzapine + Fluoxetine HCl Capsules from PharmAlliance International Labs Private Limited. Whether managing bipolar disorder, treatment-resistant depression, or psychotic symptoms, our product offers a comprehensive treatment approach to help individuals achieve symptom control and improve their quality of life. For more information, please visit our website or consult your healthcare provider.